arrow1
Footballguy
Me too....I'm in the green now..how long do I ride this horse?Have never sold any CYDY since the start. Thinking about selling enough to cover my investment. But also kinda want to LET IT RIDE !!!
Me too....I'm in the green now..how long do I ride this horse?Have never sold any CYDY since the start. Thinking about selling enough to cover my investment. But also kinda want to LET IT RIDE !!!
I'm getting close to being green also. Not sure what I'm going to do. Chet's comment the other day makes me want to hold for awhile.Me too....I'm in the green now..how long do I ride this horse?
I could sell 43% now and break even and let the other 57% ride. But that just doesn't seem as fun.Me too....I'm in the green now..how long do I ride this horse?
Good luck to you guys. I don’t have the stomach anymore for stuff like this. I got rid of 90% of mine at the peaks in July and September. Amazed that you guys held out through the vaccines and everything. No idea if you should hold, but as an FYI, my IRA which is where I had most of my CYDY is up about 50% from those two sales so it’s like I sold today at almost $10 and $8. I’d just be cautious based on the rest of your portfolio and if there’s other things you’d like to own more. Otherwise, good luck! Hope you get back to $10. I think I made myself feel better by figuring out how much extra CYDY got me after reinvesting the profits. Thanks again Chet.I'm getting close to being green also. Not sure what I'm going to do. Chet's comment the other day makes me want to hold for awhile.
Thank God NP is doing some work while you and Bezos Pal around on the golf course while Amazon does nothingCYDY working to make my account green, per usual.
Trial results coming in a month or soSo what's the reason for the run up?
Or is the reason we don't need a reason?
Link (need subscription)CytoDyn, a biotechnology company, recently applied to the FDA to test its experimental drug, leronlimab, on 102 long Covid patients.
PHOTO: CYTODYN INC.
Doctors have previously used some existing drugs to alleviate specific symptoms of long Covid in a piecemeal fashion. What’s different now is that scientists are testing drugs intended to treat the underlying causes of the condition.
CytoDyn, a Vancouver, Wash., biotechnology company, recently applied to the U.S. Food and Drug Administration to test its experimental drug, leronlimab, on 102 long Covid patients, says Scott A. Kelly, chief medical officer of the company.
Leronlimab, a monoclonal antibody administered through subcutaneous injections, was developed as an HIV drug. When the pandemic hit, the company shifted to Covid-19. The same receptor that allows HIV to enter cells is also important in regulating immune cells; some doctors believe long-term Covid symptoms are caused by the immune system going haywire. The company has recently tested the treatment in severe Covid patients as well as in mild to moderate cases, some of which were long-haul patients.
Some patients with long-term symptoms reported their brain fog and cognition issues improving after treatment. “When we started to see these patients saying the brain fog was clearing, we were encouraged,” says Dr. Kelly. A new trial would test the drug specifically on long-haul patients.
Dr. Kelly says they believe leronlimab may be alleviating brain inflammation. Leronlimab binds to a cell receptor that contributes to the regulation of immune cells that sometimes flood an area and destroy tissue. Blocking that receptor may slow down the inflammatory response, which some scientists believe is triggering problems in long Covid patients.
“We are hopeful we can control the neuroinflammation in the brain which we think causes a lot of these problems with autonomic dysfunction, fatigue, brain fog,” says Dr. Kelly. The company says patients haven’t reported significant side effects in the clinical trials they’ve done for Covid and HIV.
Dr. Kelly says the interest in such a treatment is tremendous. “I get emails every day about wanting to participate in the trial,” he says.
Nevermind.Now in the green after months of waiting for the brokerage part of my shares.
Still a little way to go for my IRA, but getting closer.
I might cry...
To the moon Alice.Whatever happened with the Nasdaq uplisting? I kind of forgot about that once it dropped to sub $4. Is that back on the table now? Would expect a big pop if that happened? Where would the price go once its "legit"
They mentioned it on the last call... I think I remember they're still a ways away due to other factors (cash on hand? assets?). Stock price helps, approval would help, but still not there yet.Whatever happened with the Nasdaq uplisting? I kind of forgot about that once it dropped to sub $4. Is that back on the table now? Would expect a big pop if that happened? Where would the price go once its "legit"
Shorts warming up the iron claw.Like the Ultimate Warrior fighting back from the sleeper hold!
what was the catalyst?
Well that may stop the momentumLooks like CFO Michael Mulholland sold 32,000 shares on 12/17, 487,002 shares on 12/18. and 589,797 shares today. He now owns 284,081 shares. In other words, he sold 75% of his shares.
https://www.sec.gov/Archives/edgar/data/1175680/000180709420000029/xslF345X03/primary_doc.xml
I don’t think the buying public knows or generally cares about this sort of thing.Well that may stop the momentum
Looks like part of a pre determined plan sale executed 11/12. Bunch of NQ’s, non-qualified stock options. The spread between the exercise price and grant price is taxable compensation (ordinary income) to him. Pretty common from lots of exec’s I have seen. Most NQ’s I see are same day exercise and sell due to tax consequences.Looks like CFO Michael Mulholland sold 32,000 shares on 12/17, 487,002 shares on 12/18. and 589,797 shares today. He now owns 284,081 shares. In other words, he sold 75% of his shares.
https://www.sec.gov/Archives/edgar/data/1175680/000180709420000029/xslF345X03/primary_doc.xml
We'll see a drop tomorrow.Looks like part of a pre determined plan sale executed 11/12. Bunch of NQ’s, non-qualified stock options. The spread between the exercise price and grant price is taxable compensation (ordinary income) to him. Pretty common from lots of exec’s I have seen. Most NQ’s I see are same day exercise and sell due to tax consequences.
Imagine he has many more ‘in the money’ options.
Its not like they were going to expire anytime soon, definitely didn't need to put this in motion now. If he was confident that this had a lot more room to run, seems odd to sell now.I don’t think the buying public knows or generally cares about this sort of thing. Does make you wonder why the hell he would do it though.
Something happen other than the CFO selling some stock?Charlie Harper said:Just when you think all is well.
I know nothing. What's your thoughts?Something happen other than the CFO selling some stock?
Very nice. Agree completely with your assessment!They received EIND approval from the FDA. I think this is a precursor to a broader approval in Jan. I think it’s positive but the stock has gone up so much recently that I’m not sure how it will react today.
https://ir.stockpr.com/cytodyn/news/detail/492
User name checks outTaxguy said:Looks like part of a pre determined plan sale executed 11/12. Bunch of NQ’s, non-qualified stock options. The spread between the exercise price and grant price is taxable compensation (ordinary income) to him. Pretty common from lots of exec’s I have seen. Most NQ’s I see are same day exercise and sell due to tax consequences.
Imagine he has many more ‘in the money’ options.
I believe EIND patients have to be approved separately and that EUA patients can be treated simply with the doctor’s approval.Knowing a EAU is a bigger deal, what is the difference between an EIND and a EAU?
Eind is go ahead and administer the patient is ####ed anyway.Knowing a EAU is a bigger deal, what is the difference between an EIND and a EAU?
Overall more red tape to get through and having to apply individually for each patient. There is an additional review board that has to approve EIND that doesn't EUA.Knowing a EAU is a bigger deal, what is the difference between an EIND and a EAU?
LOL. Well I’m sure your BIL still has his 10 dollar shares at least.Glad I sold out the rest at 2.50 a couple weeks ago. FML...